During the past decade, Aspen Woods Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aspen Woods Clinic" are "Primary Sclerosing Cholangitis (PSC)" (2 trials), "Crohn's Disease (CD)" (1 trials), "Inflammatory Bowel Disease (IBD)" (1 trials), "Primary Sclerosing Cholangitis" (1 trials) and "Ulcerative Colitis (UC)" (1 trials). Many other conditions were trialed in "Aspen Woods Clinic" in a lesser frequency.

Most popular intervention types in "Aspen Woods Clinic" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "HTD1801" (1 trials), "Inflectra" (1 trials), "PLN-74809" (1 trials) and "SpyGlass DS I - II" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aspen Woods Clinic" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Aspen Woods Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aspen Woods Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aspen Woods Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".